Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03372057
Title A Study of Duvelisib in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)
Acronym PRIMO
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | DEU


No variant requirements are available.